CTI BioPharma Corp.
OXYGEN LINKED PYRIMIDINE DERIVATIVES

Last updated:

Abstract:

The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents. More particularly, the present invention relates to oxygen linked and substituted pyrimidine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative disorders including tumours and cancers as well as other disorders or conditions related to or associated with kinases.

Status:
Application
Type:

Utility

Filling date:

2 Sep 2021

Issue date:

4 Aug 2022